BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Dai T, Zhang D, Cai M, Wang C, Wu Z, Ying Z, Wu J, Li M, Xie D, Li J. Golgi phosphoprotein 3 (GOLPH3) promotes hepatocellular carcinoma cell aggressiveness by activating the NF-κB pathway. J Pathol. 2015;235:490-501. [PMID: 25385148 DOI: 10.1002/path.4479] [Cited by in Crossref: 31] [Cited by in F6Publishing: 32] [Article Influence: 5.2] [Reference Citation Analysis]
Number Citing Articles
1 He S, Niu G, Shang J, Deng Y, Wan Z, Zhang C, You Z, Shen H. The oncogenic Golgi phosphoprotein 3 like overexpression is associated with cisplatin resistance in ovarian carcinoma and activating the NF-κB signaling pathway. J Exp Clin Cancer Res 2017;36:137. [PMID: 28978336 DOI: 10.1186/s13046-017-0607-0] [Cited by in Crossref: 9] [Cited by in F6Publishing: 6] [Article Influence: 2.3] [Reference Citation Analysis]
2 Wang K, Jiang S, Huang A, Gao Y, Peng B, Li Z, Ma W, Songyang Z, Zhang S, He M, Li W. GOLPH3 Promotes Cancer Growth by Interacting With STIP1 and Regulating Telomerase Activity in Pancreatic Ductal Adenocarcinoma. Front Oncol 2020;10:575358. [PMID: 33134174 DOI: 10.3389/fonc.2020.575358] [Reference Citation Analysis]
3 Zhou X, Xie S, Wu S, Qi Y, Wang Z, Zhang H, Lu D, Wang X, Dong Y, Liu G, Yang D, Shi Q, Bian W, Yu R. Golgi phosphoprotein 3 promotes glioma progression via inhibiting Rab5-mediated endocytosis and degradation of epidermal growth factor receptor. Neuro Oncol 2017;19:1628-39. [PMID: 28575494 DOI: 10.1093/neuonc/nox104] [Cited by in Crossref: 23] [Cited by in F6Publishing: 22] [Article Influence: 7.7] [Reference Citation Analysis]
4 Zhou C, Wang P, Tu M, Huang Y, Xiong F, Wu Y. DEPDC1 promotes cell proliferation and suppresses sensitivity to chemotherapy in human hepatocellular carcinoma. Biosci Rep 2019;39:BSR20190946. [PMID: 31189746 DOI: 10.1042/BSR20190946] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 2.5] [Reference Citation Analysis]
5 Chen Y, Wang D, Peng H, Chen X, Han X, Yu J, Wang W, Liang L, Liu Z, Zheng Y, Hu J, Yang L, Li J, Zhou H, Cui X, Li F. Epigenetically upregulated oncoprotein PLCE1 drives esophageal carcinoma angiogenesis and proliferation via activating the PI-PLCε-NF-κB signaling pathway and VEGF-C/ Bcl-2 expression. Mol Cancer 2019;18:1. [PMID: 30609930 DOI: 10.1186/s12943-018-0930-x] [Cited by in Crossref: 99] [Cited by in F6Publishing: 35] [Article Influence: 49.5] [Reference Citation Analysis]
6 Zhang J, Zhang M, Ma H, Song X, He L, Ye X, Li X. A meta-analysis of the prognostic significance of Golgi protein 73 in hepatocellular carcinoma in Chinese patients. Arch Med Sci 2020;16:1104-10. [PMID: 32863999 DOI: 10.5114/aoms.2019.83821] [Reference Citation Analysis]
7 Donizy P, Kaczorowski M, Biecek P, Halon A, Szkudlarek T, Matkowski R. Golgi-Related Proteins GOLPH2 (GP73/GOLM1) and GOLPH3 (GOPP1/MIDAS) in Cutaneous Melanoma: Patterns of Expression and Prognostic Significance. Int J Mol Sci 2016;17:E1619. [PMID: 27706081 DOI: 10.3390/ijms17101619] [Cited by in Crossref: 20] [Cited by in F6Publishing: 19] [Article Influence: 4.0] [Reference Citation Analysis]
8 Jin Z, Yan W, Jin H, Ge C, Xu Y. Psoralidin inhibits proliferation and enhances apoptosis of human esophageal carcinoma cells via NF-κB and PI3K/Akt signaling pathways. Oncol Lett 2016;12:971-6. [PMID: 27446379 DOI: 10.3892/ol.2016.4716] [Cited by in Crossref: 10] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
9 Yang M, Wu X, Li L, Li S, Li N, Mao M, Pan S, Du R, Wang X, Chen M, Xiao N, Zhu X, He G, Zhang L, Huang W, Pan H, Deng L, Chen L, Liang L, Guan J. COMMD10 inhibits tumor progression and induces apoptosis by blocking NF-κB signal and values up BCLC staging in predicting overall survival in hepatocellular carcinoma. Clin Transl Med 2021;11:e403. [PMID: 34047468 DOI: 10.1002/ctm2.403] [Reference Citation Analysis]
10 Wen Y, Tan X, Wu X, Wu Q, Qin Y, Liang M, Ran G, Gu H, Xie R. Golgi phosphoprotein 3 (GOLPH3) promotes endometrial carcinoma cell invasion and migration by regulating the epithelial-mesenchymal transition. Cancer Biomark 2019;26:21-30. [PMID: 31322544 DOI: 10.3233/CBM-190096] [Cited by in Crossref: 2] [Article Influence: 2.0] [Reference Citation Analysis]
11 Sechi S, Frappaolo A, Karimpour-Ghahnavieh A, Piergentili R, Giansanti MG. Oncogenic Roles of GOLPH3 in the Physiopathology of Cancer. Int J Mol Sci 2020;21:E933. [PMID: 32023813 DOI: 10.3390/ijms21030933] [Cited by in Crossref: 15] [Cited by in F6Publishing: 8] [Article Influence: 15.0] [Reference Citation Analysis]
12 Xia J, Huang N, Huang H, Sun L, Dong S, Su J, Zhang J, Wang L, Lin L, Shi M, Bin J, Liao Y, Li N, Liao W. Voltage-gated sodium channel Nav 1.7 promotes gastric cancer progression through MACC1-mediated upregulation of NHE1. Int J Cancer. 2016;139:2553-2569. [PMID: 27529686 DOI: 10.1002/ijc.30381] [Cited by in Crossref: 38] [Cited by in F6Publishing: 33] [Article Influence: 7.6] [Reference Citation Analysis]
13 El-Maqsoud NMRA, Osman NAA, El-Hamid AMA, El-Bab TKF, Galal EM. GOLPH3 and YB-1 Are Novel Markers Correlating With Poor Prognosis in Prostate Cancer. World J Oncol 2015;6:473-84. [PMID: 28983350 DOI: 10.14740/wjon952w] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 0.7] [Reference Citation Analysis]
14 Sechi S, Frappaolo A, Belloni G, Colotti G, Giansanti MG. The multiple cellular functions of the oncoprotein Golgi phosphoprotein 3. Oncotarget 2015;6:3493-506. [PMID: 25691054 DOI: 10.18632/oncotarget.3051] [Cited by in Crossref: 34] [Cited by in F6Publishing: 28] [Article Influence: 6.8] [Reference Citation Analysis]
15 Kuna RS, Field SJ. GOLPH3: a Golgi phosphatidylinositol(4)phosphate effector that directs vesicle trafficking and drives cancer. J Lipid Res 2019;60:269-75. [PMID: 30266835 DOI: 10.1194/jlr.R088328] [Cited by in Crossref: 24] [Cited by in F6Publishing: 12] [Article Influence: 8.0] [Reference Citation Analysis]
16 Qiu CZ, Wang MZ, Yu WS, Guo YT, Wang CX, Yang XF. Correlation of GOLPH3 Gene with Wnt Signaling Pathway in Human Colon Cancer Cells. J Cancer 2016;7:928-34. [PMID: 27313783 DOI: 10.7150/jca.13968] [Cited by in Crossref: 17] [Cited by in F6Publishing: 15] [Article Influence: 3.4] [Reference Citation Analysis]
17 Zhang Y, Wang J, Su H. MiR-3150b inhibits hepatocellular carcinoma cell proliferation, migration and invasion by targeting GOLPH3. J Investig Med 2020;68:770-5. [PMID: 31806673 DOI: 10.1136/jim-2019-001181] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
18 Arriagada C, Luchsinger C, González AE, Schwenke T, Arriagada G, Folch H, Ehrenfeld P, Burgos PV, Mardones GA. The knocking down of the oncoprotein Golgi phosphoprotein 3 in T98G cells of glioblastoma multiforme disrupts cell migration by affecting focal adhesion dynamics in a focal adhesion kinase-dependent manner. PLoS One 2019;14:e0212321. [PMID: 30779783 DOI: 10.1371/journal.pone.0212321] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 3.5] [Reference Citation Analysis]
19 Abd El-Maqsoud NM, Osman NA, Abd El-Hamid AM, Fath El-Bab TK, Galal EM. Golgi Phosphoprotein-3 and Y-Box-Binding Protein-1 Are Novel Markers Correlating With Poor Prognosis in Prostate Cancer. Clin Genitourin Cancer 2016;14:e143-52. [PMID: 26794392 DOI: 10.1016/j.clgc.2015.12.015] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.8] [Reference Citation Analysis]
20 Rizzo R, Parashuraman S, D’angelo G, Luini A. GOLPH3 and oncogenesis: What is the molecular link? Tissue and Cell 2017;49:170-4. [DOI: 10.1016/j.tice.2016.06.008] [Cited by in Crossref: 25] [Cited by in F6Publishing: 23] [Article Influence: 6.3] [Reference Citation Analysis]
21 Ijuin T, Takeuchi Y, Shimono Y, Fukumoto M, Tokuda E, Takenawa T. Regulation of CD44 expression and focal adhesion by Golgi phosphatidylinositol 4-phosphate in breast cancer. Cancer Sci 2016;107:981-90. [PMID: 27178239 DOI: 10.1111/cas.12968] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 1.0] [Reference Citation Analysis]
22 Arriagada C, Cavieres VA, Luchsinger C, González AE, Muñoz VC, Cancino J, Burgos PV, Mardones GA. GOLPH3 Regulates EGFR in T98G Glioblastoma Cells by Modulating Its Glycosylation and Ubiquitylation. Int J Mol Sci 2020;21:E8880. [PMID: 33238647 DOI: 10.3390/ijms21228880] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
23 Kanda M, Sugimoto H, Kodera Y. Genetic and epigenetic aspects of initiation and progression of hepatocellular carcinoma. World J Gastroenterol. 2015;21:10584-10597. [PMID: 26457018 DOI: 10.3748/wjg.v21.i37.10584] [Cited by in CrossRef: 37] [Cited by in F6Publishing: 41] [Article Influence: 7.4] [Reference Citation Analysis]
24 Dwane L, Gallagher WM, Ní Chonghaile T, O'Connor DP. The Emerging Role of Non-traditional Ubiquitination in Oncogenic Pathways. J Biol Chem 2017;292:3543-51. [PMID: 28154183 DOI: 10.1074/jbc.R116.755694] [Cited by in Crossref: 26] [Cited by in F6Publishing: 19] [Article Influence: 6.5] [Reference Citation Analysis]
25 Tenorio MJ, Ross BH, Luchsinger C, Rivera-Dictter A, Arriagada C, Acuña D, Aguilar M, Cavieres V, Burgos PV, Ehrenfeld P, Mardones GA. Distinct Biochemical Pools of Golgi Phosphoprotein 3 in the Human Breast Cancer Cell Lines MCF7 and MDA-MB-231. PLoS One 2016;11:e0154719. [PMID: 27123979 DOI: 10.1371/journal.pone.0154719] [Cited by in Crossref: 12] [Cited by in F6Publishing: 11] [Article Influence: 2.4] [Reference Citation Analysis]
26 Li W, Guo F, Gu M, Wang G, He X, Zhou J, Peng Y, Wang Z, Wang X. Increased Expression of GOLPH3 is Associated with the Proliferation of Prostate Cancer. J Cancer 2015;6:420-9. [PMID: 25874005 DOI: 10.7150/jca.11228] [Cited by in Crossref: 8] [Cited by in F6Publishing: 11] [Article Influence: 1.3] [Reference Citation Analysis]
27 Paul I, Batth TS, Iglesias-Gato D, Al-Araimi A, Al-Haddabi I, Alkharusi A, Norstedt G, Olsen JV, Zadjali F, Flores-Morales A. The ubiquitin ligase Cullin5SOCS2 regulates NDR1/STK38 stability and NF-κB transactivation. Sci Rep 2017;7:42800. [PMID: 28216640 DOI: 10.1038/srep42800] [Cited by in Crossref: 19] [Cited by in F6Publishing: 16] [Article Influence: 4.8] [Reference Citation Analysis]
28 Øverbye A, Skotland T, Koehler CJ, Thiede B, Seierstad T, Berge V, Sandvig K, Llorente A. Identification of prostate cancer biomarkers in urinary exosomes. Oncotarget 2015;6:30357-76. [PMID: 26196085 DOI: 10.18632/oncotarget.4851] [Cited by in Crossref: 118] [Cited by in F6Publishing: 105] [Article Influence: 23.6] [Reference Citation Analysis]
29 Wu S, Fu J, Dong Y, Yi Q, Lu D, Wang W, Qi Y, Yu R, Zhou X. GOLPH3 promotes glioma progression via facilitating JAK2-STAT3 pathway activation. J Neurooncol 2018;139:269-79. [PMID: 29713848 DOI: 10.1007/s11060-018-2884-7] [Cited by in Crossref: 11] [Cited by in F6Publishing: 14] [Article Influence: 3.7] [Reference Citation Analysis]
30 Liu H, Wang X, Feng B, Tang L, Li W, Zheng X, Liu Y, Peng Y, Zheng G, He Q. Golgi phosphoprotein 3 (GOLPH3) promotes hepatocellular carcinoma progression by activating mTOR signaling pathway. BMC Cancer 2018;18:661. [PMID: 29914442 DOI: 10.1186/s12885-018-4458-7] [Cited by in Crossref: 11] [Cited by in F6Publishing: 12] [Article Influence: 3.7] [Reference Citation Analysis]
31 Tang S, Pan H, Wei W, Yang H, Liu J, Yang R. GOLPH3: a novel biomarker that correlates with poor survival and resistance to chemotherapy in breast cancer. Oncotarget 2017;8:105155-69. [PMID: 29285241 DOI: 10.18632/oncotarget.21927] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 2.3] [Reference Citation Analysis]
32 Shi W, Feng W, Wang J, Zhai C, Zhang Q, Wang Q, Song Y, Yan X, Chai L, Liu P, Chen Y, Li C, Li M. Clinicopathologic Features and Prognostic Implications of Golgi Phosphoprotein 3 in Non-small Cell Lung Cancer: A Meta-analysis. J Cancer 2019;10:5754-63. [PMID: 31737112 DOI: 10.7150/jca.30067] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]